✦ LIBER ✦

Effect of the menopause and hormone replacement therapy on the carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen

✍ Scribed by C. Hassager; J. Risteli; L. Risteli; C. Christiansen

Publisher: Springer-Verlag
Year: 1994
Tongue: English
Weight: 437 KB
Volume: 4
Category: Article
ISSN: 0937-941X
DOI: 10.1007/bf01622196

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The carboxy-terminal pyridinoline cross-

The carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen in serum as a marker of bone resorption: The effect of nandrolone decanoate and hormone replacement therapy

✍ C. Hassager; L. T. Jensen; J. Pødenphant; K. Thomsen; C. Christiansen 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 375 KB

The effect of the menopause and hormone

The effect of the menopause and hormone replacement therapy on serum carboxyterminal propeptide of type I collagen

✍ C. Hassager; G. Fabbri-Mabelli; C. Christiansen 📂 Article 📅 1993 🏛 Springer-Verlag 🌐 English ⚖ 396 KB

Comparison of serum levels of pyridinoli

Comparison of serum levels of pyridinoline and pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen as markers of bone resorption in patients receiving maintenance hemodialysis

✍ Shoji Samma; Masanori Joko; Nobumichi Tanaka; Tatsuya Akiyama; Yoriaki Kagebayas 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 748 KB

Use of bone turnover marker, pyridinolin

Use of bone turnover marker, pyridinoline cross-linked carboxyterminal telopeptide of type I collagen (ICTP), in the assessment and monitoring of bone metastasis in prostate cancer

✍ Koga, Hirofumi; Naito, Seiji; Koto, Shuji; Sakamoto, Naotaka; Nakashima, Michita 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB 👁 2 views

BACKGROUND. We investigated whether a new marker of bone turnover, pyridinoline cross-linked carboxyterminal telopeptide of type I collagen (ICTP), could be useful in the assessment of bone metastasis and in monitoring of the response to treatment in patients with prostate cancer with bone metastasi